PLX PHARMA INC's ticker is PLXP and the CUSIP is 72942A107. A total of 4 filers reported holding PLX PHARMA INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $3,000 | -25.0% | 26,507 | 0.0% | 0.00% | – |
| Q4 2022 | $4,000 | -78.9% | 26,507 | -10.9% | 0.00% | – |
| Q3 2022 | $19,000 | -74.0% | 29,757 | 0.0% | 0.00% | – |
| Q2 2022 | $73,000 | -44.3% | 29,757 | -9.2% | 0.00% | – |
| Q1 2022 | $131,000 | -22.5% | 32,757 | +55.4% | 0.00% | – |
| Q4 2021 | $169,000 | -62.6% | 21,075 | -10.0% | 0.00% | -100.0% |
| Q3 2021 | $452,000 | – | 23,409 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ground Swell Capital, LLC | 42,509 | $28,000 | 0.08% |
| MSD Partners, L.P. | 1,303,800 | $847,000 | 0.07% |
| Park West Asset Management LLC | 1,473,218 | $958,000 | 0.07% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 125,346 | $81,000 | 0.03% |
| STEEL GROVE CAPITAL ADVISORS, LLC | 193,000 | $125,000 | 0.02% |
| Eidelman Virant Capital | 27,000 | $17,000 | 0.01% |
| O'Brien Greene & Co. Inc | 67,020 | $44,000 | 0.01% |
| SHUFRO ROSE & CO LLC | 82,100 | $53,000 | 0.01% |
| MBL Wealth, LLC | 26,000 | $17 | 0.00% |
| Clearline Capital LP | 23,844 | $15,000 | 0.00% |